Results 221 to 230 of about 1,206,208 (293)

Butyrate-producing gut bacterium <i>Faecalibacterium prausnitzii</i> protects against bacterial pneumonia. [PDF]

Eur Respir J
Kullberg RFJ, van Linge CCA, de Vos AF, Brands X, Bui TPN, Butler JM, Faber DR, Verhoeven A, van den Wijngaard RM, de Jonge WJ, Nieuwdorp M, van der Poll T, Haak BW, Wiersinga WJ.   +13 more
europepmc   +1 more source

Are hospitalised acute rheumatic fever and rheumatic heart disease cases notified to the Western Australian Register in the Pilbara region? A retrospective review, 2016–2023

Internal Medicine Journal, EarlyView.
Abstract Background Acute rheumatic fever (ARF) and rheumatic heart disease (RHD) are prevalent among First Nations peoples in Australia. In Western Australia (WA), notification of ARF and RHD to the WA RHD register is mandatory and supports follow‐up care.
Aung Du, Ingrid Stacey, Judith M. Katzenellenbogen, Pauline Glasson, Sharon Lockyer, Emma Corpus, Simon Slota‐Kan   +6 more
wiley   +1 more source

Safety and Efficacy of Nebulized Inhalation of Polymyxin B Sulfate for Carbapenem-Resistant Gram-Negative Bacterial Pneumonia: A Multi-Center, Prospective, Observational Study. [PDF]

Infect Drug Resist
Zhu M, Zhang J, Han Y, Zheng X, Xu Q, Chen Q, Chen S, Yao Y, Jiang R, Wu J, Zhou H, Lei S.   +11 more
europepmc   +1 more source

Tigecycline combination therapy for fulminant Clostridioides difficile infection: an Australian experience

Internal Medicine Journal, EarlyView.
Abstract Background Recent European Society of Clinical Microbiology and Infection and Australasian Society of Infectious Diseases Clostridioides difficile infection (CDI) management guidelines endorse the addition of intravenous tigecycline in patients who are progressing to fulminant infection.
Emma Bishop, Tanya Ravipati, Steven Mileto, Eugene Athan, Dena Lyras, Ravindranath Tiruvoipati   +5 more
wiley   +1 more source

Characterization of two exoU⁺/exoS⁺ carbapenem-non-susceptible Pseudomonas aeruginosa co-colonizing the lung of a bacterial pneumonia patient. [PDF]

BMC Microbiol
Yan Y, Qian L, Feng X, Zhang F, Tang M, Chen H, Li Y, Zhang L.   +7 more
europepmc   +1 more source

ANZTCT cytomegalovirus practice survey for allogeneic haemopoietic stem cell transplant and cellular therapy recipients in Australia and New Zealand

Internal Medicine Journal, EarlyView.
Abstract Background Despite pre‐emptive treatment (PeT), cytomegalovirus (CMV) disease and reactivation remain a clinical concern. In Australia and New Zealand (ANZ), variability exists in the management of CMV for haematopoietic stem cell transplantation (HSCT) recipients.
Andrea Henden, Lynette Chee, Julia Clark, Rachel Conyers, Julian Cooney, Richard Doocey, David Gottlieb, Tim Prestidge, Madeleine Powys, Philip Selby, Gaurav Sutrave, Eric Wong, Michelle K. Yong, Nada Hamad   +13 more
wiley   +1 more source

Adrenergic receptors: a key determinant of outcomes in bacterial pneumonia and bacterial sepsis-associated acute lung injury/acute respiratory distress syndrome through participation in pulmonary innate immune response. [PDF]

Front Immunol
Zeng L, Yang J, Yan J.
europepmc   +1 more source

Respiratory and Pleural Pathogens in Octogenarians Hospitalized with COVID-19: Impact of Secondary Bacterial Pneumonia on Day-5 SOFA and Mortality. [PDF]

Microorganisms
Daliu P, Bratosin F, Rosca O, Licker M, Hogea E, Stanga L, Gurban CV, Muntean D.   +7 more
europepmc   +1 more source

Lefamulin versus omadacycline for community acquired bacterial pneumonia: a systematic review and anchored indirect treatment comparison using moxifloxacin as the common comparator. [PDF]

J Comp Eff Res
Wu M, Han S, Li H.
europepmc   +1 more source

Safety of Damoctocog Alfa Pegol in Patients With Severe Haemophilia A Aged 7 to <12 Years of Age: Pooled Data From PROTECT VIII Kids and Alfa‐PROTECT

Haemophilia, EarlyView.
Margareth C. Ozelo, Anthony K. C. Chan, Matteo Luciani, Monika Maas Enriquez, Claudia Tueckmantel, Maria Elisa Mancuso   +5 more
wiley   +1 more source